Universitätsklinikum Würzburg

7-T Potassium (39K) MRI to Assess Muscle K+ Depletion in Primary Aldosteronism (2026) Kopp C, Dahlmann A, Gast L, Linz P, Frielinghaus J, Breunig P, Stroebel A, et al. Journal article External quality assessment in antimicrobial susceptibility testing (EUCAST disc diffusion methodology) of five anaerobic strains – performance of 35 laboratories in Germany and Austria, 2024 (2026) Buhl M, Jung J, Stingu CS, Copsey-Mawer S, Held J, Haase G, Sieg M, et al. Journal article Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia (2026) Menden B, Incebacak Eltemur RD, Demidov G, Sturm M, Park J, Huridou C, Fath F, et al. Journal article hiPSC-derived cortical neurons from ADHD individuals reveal dysregulated glutamatergic development (2026) McNeill RV, Schickardt Z, Radtke F, Blum R, Kittel-Schneider S Journal article Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries (2026) Von Hoff K, Obrecht-Sturm D, Ghasemi DR, Wenning J, Mynarek M, Gerber NU, Benesch M, et al. Journal article Pediatric high-grade gliomas in patients with neurofibromatosis type 1 - A collaborative cohort study from the SIOPE HGG/DIPG working group (2026) Karremann M, Gerdes T, Gielen GH, Kwiecien R, Perwein T, Hoffmann M, Azizi AA, et al. Journal article Impact of drug-induced immunosuppression following kidney transplantation on periodontal health and the periodontal microbiome: a longitudinal controlled study (2026) Flierl E, Lutz R, Heller KM, Schiffer M, Wirtz S, Backhaus J, Weber M, et al. Journal article Heterogeneity of Estimated GFR Slopes According to Etiology, Estimated GFR and Urinary Albumin-to-Creatinine Ratio in a Large Cohort of Patients With CKD (2026) Behning C, Schultheiss UT, Nadal J, Meiselbach H, Schönherr S, Forer L, Schaeffner E, et al. Journal article Rare genetic variants confer a high risk of ADHD and implicate neuronal biology (2026) Demontis D, Duan J, Hsu YHH, Pintacuda G, Grove J, Nielsen TT, Thirstrup J, et al. Journal article Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX). (2026) Burchert A, Nicolini FE, le Coutre P, Saussele S, Hochhaus A, Tuere E, Metzelder SK, et al. Journal article